.jpg)
Find a Program
Find a Lab
Laboratory Director
Lung Cancer Systems Genetics
Support the Lab
Putting Drug Development In Patients' Hands
plustag.jpg)
Principal Investigators
 David Jablons M.D. Director, Thoracic Oncology Laboratory
David Jablons is Director of the Thoracic Oncology Laboratory as well as Program Leader of Thoracic Oncology at the UCSF Helen Diller Family Comprehensive Cancer. Dr. Jablons leads a team of dedicated researchers seeking to discover of therapeutic agents and cures for lung cancer and mesothelioma. He recruited Liang You, M.D. Ph.D., Zhidong Xu Ph.D., and Biao He, Ph.D. to the lab to pursue target discovery and novel therapies for lung cancer and mesothelioma and other cancers. |
 Biao He, Ph.D. Assistant Adjunct Professor of Surgery
Biao He is a molecular geneticist in the Thoracic Oncology Laboratory. Dr. He was recruited for his knowledge of Wnt signaling and RNA interference (RNAi). His current research includes exploration of the molecular mechanisms of non-small cell lung cancer and malignant mesothelioma and development of novel targeted small molecule and monoclonal antibody therapies.
|
 Zhidong Xu, Ph.D. Assistant Adjunct Professor of Surgery
Zhidong Xu, Ph.D. is a molecular biologist and senior scientist in the Thoracic Oncology Laboratory. In 1998, Dr. Xu was recruited by David M. Jablons, MD to the Thoracic Oncology Laboratory. In 2001, he joined the faculty at the UCSF School of Medicine as an Assistant Professor in the Department of Surgery. |
 Liang You, M.D., Ph.D Assistant Adjunct Professor of Surgery Liang You came to the Thoracic Oncology Laboratory after several years at the National Cancer Institute. Dr. You has helped identify several novel biomarkers and therapeutic targets in lung cancer and mesothelioma. He is currently investigating recombinant human WIF-1 protein as a cancer therapy and seeking out new therapeutic targets and novel interventions. |